Barclays Maintains Overweight on DexCom, Raises Price Target to $120
Benzinga Newsdesk 22 hours ago
Analyst RatingsNewsPrice Target
Barclays analyst Christopher Pasquale maintains DexCom (NASDAQ:DXCM) with a Overweight and raises the price target from $115 to $120.
Barclays analyst Christopher Pasquale maintains DexCom (NASDAQ:DXCM) with a Overweight and raises the price target from $115 to $120.